Skip to main content

Full text of "USPTO Patents Application 10727780"

See other formats


PATENT 



UNITED STATES PATENT AND TRADEMARK OFFICE 

(Case No. 03-1070 (400.139)) 



Filed: 



Serial No. 



HE APPLICATION OF: 



McSwiggen et al. 



December 3, 2003 



10/727,780 




Group Art Unit: 



Examiner: 



To Be Assigned 



1645 



Title 



Inhibition of Gene Expression Using 
Duplex Forming Oligonucleotides 



Confirmation No.: 



7111 



TRANSMITTAL LETTER 



Mail Stop Missing Parts 
Commissioner for Patents 
P.O. Box 1450 
Alexandria, VA 22313-1450 

Dear Sir or Madam: 

In regard to the above identified application: 

1 . We are transmitting herewith the attached: 

a. Response to the Notice to Comply; 

b. Copy of Notice to Comply; 

c. Petition for One Month Extension of Time 

d. Sequence Listing Compliance Statement 

e. Transmittal letters for Copy 1 and Copy 2 cd-roms 

f. Return Receipt Postcard. 

2. With respect to additional fees, 

L*] A check in the amount of $60.00 is enclosed in compliance with 37 CFR 1.17(a)(1) 

3. GENERAL AUTHORIZATION: Please charge any additional fees or credit overpayment to Deposit 
Account No. 1 3-2490. A duplicate copy of this sheet is enclosed. 

4. CERTIFICATE OF MAILING UNDER 37 CFR § 1.8: The undersigned hereby certifies that this 
Transmittal Letter and the paper, as described in paragraph 1 hereinabove, are being deposited with the 
United States Postal Service with sufficient postage as first class mail in an envelope addressed to: Mail 
Stop Missing Parts, Commissioner for Patents, P. O. Box 1450, Alexandria, VA 22313-1450, on June 10, 
2005. 



Date: June 10, 2005 




McDonnell Boehnen Hulbert & Berghoff LLP 
300 South Wacker Drive, 32 nd Floor 
Chicago, IL 60606 
Telephone: (312)913-0001 
Facsimile: (312) 913-0002 



1 



Application No. 1 0/727,803 
Response to Notice to Comply June 10^ 2005 
Attorney Docket No.03-1070 (400.139) 




PATENT 



UNITED STATES PATENT AND TRADEMARK OFFICE 

. (Case No. 03-1070 (400.139)) 



IN' THE APPLICATION OF: 



McSwiggen et al. 
Serial No. 10/727,780 
Filed: December 3, 2003 

Title 



Inhibition of Gene Expression Using 
Duplex Forming Oligonucleotides 



Examiner: To Be Assigned 

Group Art Unit: 1645 
Confirmation No. : 7111 



RESPONSE TO NOTICE TO COMPLY 

Mail Stop Missing Parts 
Commissioner for Patents 
P.O. Box 1450 
Alexandria, VA 22313-1450 

Sir: 

Responsive to the Notice to Comply with requirements for Patent Applications Containing 
Nucleotide Sequence And/Or Amino Acid Sequence Disclosures, mailed March 11, 2005, of 
which a copy is attached, Applicants submit herewith the following Sequence Listing on CD-rom, 
in duplicate form and Computer Readable form complying with the requirements of 37 CFR 
1.822 and/or 1.823. 

Respectfully submitted, 

McDonnell Boehnen Hulbert & Berghoff LLP 



Date: June 10, 2005 




n J. Derry 
No. 50,692 




Page 1 of 2 



TF 




United States Patent and Trademark Office 



UNITED STATES DEPARTMENT OF COMMERCE 
United State* Patent and Trademark Officie 
Addrcsi: COMMISSIONER FOR PATENTS 
P.O. Dox 1450 

Alexandria, Vugmia 22313-1450 
www.iwplo.gov 



APPLICATION NUMBER 



FILING OR 371"(c7DATE 



FIRST NAMED APPLICANT 



ATTORNEY DOCKET NUMBER 



10/727,780 



12/03/2003 



James McSwiggen 



MBHB03-1070 (400/139) 



020306 

MCDONNELL BOEHNEN HULBERT & BE 
300 S. WACKER DRIVE 
32ND FLOOR 
CHICAGO, IL 60606 




CONFIRMATION NO. 7111 
FORMALITIES LETTER 

in 

*OC00000001 5425807* 



Date Mailed: 03/11/2005 



NOTICE TO COMPLY WITH REQUIREMENTS FOR PATENT APPLICATIONS 
CONTAINING NUCLEOTIDE SEQUENCE AND/OR AMINO ACID SEQUENCE 

DISCLOSURES 

Filing Date Granted 

Applicant is given TWO MONTHS FROM THE DATE OF THIS NOTICE within which to file the items indicated 
below to avoid abandonment. Extensions of time may be obtained under the provisions of 37 CFR 1 .136(a). 



• A copy of the "Sequence Listing" in computer readable form has been submitted. However, the content of 
the computer readable form does not comply with the requirements of 37 CFR 1 .822 and/or 1 .823, as 
indicated on the attached copy of the marked -up "Raw Sequence Listing." Applicant must provide a * 
substitute computer readable form (CRF) copy of the "Sequence Listing" and a statement that the conterrj , 
of the sequence listing information recorded in computer readable form is identical to the written (on pape^/ 
or compact disc) sequence listing and, where applicable, includes no new matter, as required by 37 CFR 
1 .821 (e), 1 .821 (f), 1 .821 (g), 1 .825(b), or 1 .825(d). 



To Download Patentin Software, visit http://www.uspto.gov/web/patents/software.htm 
< For questions regarding compliance to these requirements, please contact: 

• For Rules Interpretation, call (571) 272-0951 

*\ • For Patentin Software Program Help, call Patent EBC at 1-866-217-9197 or directly at 703-305- 
3028 / 703-308-6845 between the hours of 6 a.m. and 12 midnight, Monday through Friday, 1 
EST. 

• Send e-mail correspondence for Patentin Software Program Help @ ebc@uspto.gov 



Replies should be mailed to: Mail Stop Missing Parts 

Commissioner for Patents 
P.O. Box 1450 
Alexandria VA 22313-1450 



A copy of this notice MUST be returned with the reply. 



Page 2 of 2 



Customer Service Center 

Initial Patent Examination Division (703) 308-1202 

PART 2 - COPY TO BE RETURNED WITH RESPONSE 



\ 

4